About this trial
Overall, this study will investigate the functional utility of stereotyped HFOs by capturing them with a new implantable system (Brain Interchange - BIC of CorTec), which can sample neural data at higher rates \>=1kHz and deliver targeted electrical stimulation to achieve seizure control. In contrast to current closed-loop systems (RNS), which wait for the seizure to start before delivering stimulation, the BIC system will monitor the spatial topography and rate of stereotyped HFOs and deliver targeted stimulation to these HFO generating areas to prevent seizures from occurring. If the outcomes of our research in an acute setting become successful, the investigators will execute a clinical trial and run the developed methods with the implantable BIC system in a chronic ambulatory setting.
Eligibility criteria
Qualifiers
Patients with medically refractory epilepsy, who have been deemed appropriate candidates for intracranial EEG monitoring
Adult men and women (18≤ age <70 years)
Children (3≤ age <18 years)
Includes women and minorities
Disqualifiers
None
Trial design
Treatments tested in this trial
- Brain Interchange System
Treatment groups
Sponsors and collaborators
Mayo Clinic
Lead sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborator
Baylor College of Medicine
Collaborator
CorTec GmbH
Collaborator